
HPV Vaccine’s Protective Reach Extends to Men, Reducing Head and Neck Cancers
An observational US study finds that the HPV vaccine, originally aimed at preventing cervical cancer in women, is associated with about a 70% lower incidence of head and neck cancers in men, especially oropharyngeal cancer. While not yet proving causation, the data suggest broad cancer-prevention benefits and reinforce the push for gender-neutral HPV vaccination beyond protecting cervical cancer.






